1. Home
  2. IMSR vs DNA Comparison

IMSR vs DNA Comparison

Compare IMSR & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Terrestrial Energy Inc.

IMSR

Terrestrial Energy Inc.

HOLD

Current Price

$4.94

Market Cap

571.5M

Sector

N/A

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$7.61

Market Cap

599.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMSR
DNA
Founded
2013
2008
Country
United States
United States
Employees
74
485
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
571.5M
599.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IMSR
DNA
Price
$4.94
$7.61
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
2.0M
1.2M
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.38
$5.37
52 Week High
$16.38
$17.58

Technical Indicators

Market Signals
Indicator
IMSR
DNA
Relative Strength Index (RSI) 32.05 34.80
Support Level N/A $6.21
Resistance Level $7.07 $10.27
Average True Range (ATR) 0.45 0.70
MACD -0.15 -0.26
Stochastic Oscillator 18.87 0.70

Price Performance

Historical Comparison
IMSR
DNA

About IMSR Terrestrial Energy Inc.

Terrestrial Energy Inc is a technology company engaged in the development and commercialization of nuclear power plants. The company is focused on its proprietary Integral Molten Salt Reactor (IMSR) technology, a Generation IV reactor design intended to produce reliable, emission-free energy in the form of electricity and high-temperature heat for industrial applications. Its activities mainly involve advancing the design, licensing, and deployment of IMSR plants for commercial energy generation.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: